--2025/Q1-- / 86.450M--
--2024/Q4-- / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--
May 9, 20242024/Q186.604M / 79.499M--
CA Stock MarketDetailed Quotes
GUD Knight Therapeutics Inc
- 5.300
- +0.090+1.73%
15min DelayMarket Closed Nov 21 16:00 ET
534.25MMarket Cap-18275P/E (TTM)
5.300High5.200Low97.32KVolume5.200Open5.210Pre Close511.52KTurnover6.23052wk High0.11%Turnover Ratio100.80MShares5.07052wk Low-0.29EPS TTM455.97MFloat Cap11.030Historical HighLossP/E (Static)86.03MShs Float3.510Historical Low-0.16EPS LYR1.92%Amplitude--Dividend TTM0.69P/B1Lot Size--Div YieldTTM
Knight Therapeutics Inc Key Stats
Knight Therapeutics Inc Q3 2024 Earnings Date
Currency：CADNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 89.43M | 92.26M | +2.84M |
| Beat Est. | +9.72% | +13.21% | +3.17% |
| EPS | 0.02 | <0.01 | -0.02 |
| Miss Est. | -75.00% | -99.07% | -96.27% |
Knight Therapeutics Inc Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Knight Therapeutics Inc Earnings Reports
Read more
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data